Table 1.

Baseline and procedural characteristics

	All patients n=30
Age (years)	81±5
Female sex	14 (47%)
Hypertension	22 (73%)
Diabetes	7 (23%)
Coronary artery disease	16 (53%)
Prior stroke	3 (10%)
STS PROM, %	2.9±2.6
Mean transvalvular gradient, mm Hg	49±17
Aortic valve area, cm²	0.8±0.2
LVEF, %	62±9
Annulus size (mm, IQR)
Short diameter	22 (21–23)
Long diameter	26 (25–28)
Device landing zone calcification
None	13 (43%)
Mild	9 (30%)
Moderate	8 (27%)
Severe	0 (0%)
Leaflet calcification
None	0 (0%)
Mild	6 (20%)
Moderate	15 (50%)
Severe	9 (30%)
Valve size
Small	7 (23%)
Medium	12 (40%)
Large	11 (37%)
Degree of valve oversizing (%)	6.0 (2.0–9.0)
Cover index (%)	5.3 (2.0–8.0)
Predilatation	28 (98%)
Postdilatation	8 (27%)
Implantation depth (mm, IQR)	4 (3–5)
Conscious sedation	30 (100%)
Procedure duration min, IQR	47 (35–57)
Conversion to surgery	0 (0%)

Data are displayed as n (%) or mean±SD or median (IQR).

Cover index defined as 100×((prosthesis diameter–CT annulus diameter)/prosthesis diameter).

LVEF, left ventricular ejection fraction; STS PROM, Society of Thoracic Surgeons Predicted Risk of Mortality.